We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Human|
|Blocking Reagent (BR)||1 Antibodies|
|Enzyme Immunoassay (EIA)||20 Antibodies|
|Flow Cytometry (FACS)||1 Antibodies|
|Functional Studies (Func)||11 Antibodies|
|Immunocytochemistry (ICC)||6 Antibodies|
|Immunofluorescence (IF)||7 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||22 Antibodies|
|Immunohistochemistry (IHC)||43 Antibodies|
|Immunohistochemistry (Frozen Sections) (IHC (fro))||7 Antibodies|
|Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))||51 Antibodies|
|Immunoprecipitation (IP)||12 Antibodies|
|Antigen||Vascular Endothelial Growth Factor A (VEGFA) Antibodies|
|Epitope||AA 27-191, Isoform 165 Alternatives|
|Conjugate||This VEGF antibody is un-conjugated Alternatives|
Enzyme Immunoassay (EIA), Functional Studies (Func), Immunoprecipitation (IP)
|3 references available|
|Supplier||Log in to see|
Product Details anti-VEGF AntibodyTarget Details VEGF Application Details Handling References for anti-VEGF Antibody (ABIN115672) Images
|Specificity||The antibody will detect Human VEGF-A.|
|Purification||Protein A Affinity Chromatography|
|Immunogen||Highly purified Recombinant Human VEGF165 [Ala27-Arg191] produced in Insect cells (Cat.-No DA3514X)|
Target Details VEGFProduct Details anti-VEGF Antibody Application Details Handling References for anti-VEGF Antibody (ABIN115672) Images back to top
|Alternative Name||VEGF-A (VEGFA Antibody Abstract)|
|Background||Human Vascular Endothelial Growth Factor VEGF165, a 23 kDa protein consisting of 165 amino acid residues, is produced as a homodimer. VEGF is a polypeptide growth factor and a member of the platelet-derived growth factor family. It is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. Two high-affinity tyrosine kinase receptors for VEGF165 have been identified, VEGFR-1 (FLT-1), and VEGFR-2 (KDR). Consistent with the endothelial cell-specific action of VEGF165, expression of both receptor genes has been found predominantly but not exclusively on endothelial cells. Expression of VEGFR-1 was also found on human monocytes, neutrophils (PMNs), bovine brain pericytes and villous and extra villous trophoblast. In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. VEGF165 is also a chemo attractant molecule for monocytes and endothelial cells. 5 different proteins are generated by differential splicing: VEGF121, VEGF145, VEGF165, VEGF189 and VEGF206. The most abundant form is VEGF165. Whereas VEGF121 and VEGF165 are secreted proteins, VEGF145, VEGF189 and VEGF206 are strongly cell-associated. The isoforms VEGF145, VEGF165 and VEGF189 bind to heparin with high affinity. VEGF165 is apparently a homo-dimer, but preparations of VEGF165 show some heterogeneity on SDS gels, depending on the secretion of different glycosylation patterns. All dimeric forms have similar biological activities but their bioavailability is very different. There is good evidence that different cells and tissues express different VEGF isoforms. The other members of this increasing growth factor family are VEGF-B, -C, -D and -E. Another member is the Placenta growth factor PlGF.Synonyms: VEGF, VEGFA, VPF, Vascular endothelial growth factor A, Vascular permeability factor|
|Research Area||Cytokines, Growth Factors, Receptors, Immunology, Inflammation, Signaling|
Application DetailsProduct Details anti-VEGF Antibody Target Details VEGF Handling References for anti-VEGF Antibody (ABIN115672) Images back to top
Neutralization: 1-2.5 μg/mL, to yield one-half maximal inhibition (ND50) of the biologicalactivity of human VEGF (50 ng/mL). ELISA: 0.5 μg/mL, allows the detection of 0.5-1.0 ng/well of recombinant human VEGF165 orother VEGF splice forms. Immunoprecipitation: 1-5 μg/mL lysate or reaction volume.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-VEGF Antibody Target Details VEGF Application Details References for anti-VEGF Antibody (ABIN115672) Images back to top
|Reconstitution||Restore in sterile water to a concentration of 0.1-1.0 mg/mL.|
|Buffer||PBS, pH 7.4 containing no preservatives|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
|Storage Comment||Prior to reconstitution store at 2-8 °C. Following reconstitution store the antibody at -20 °C.|
References for anti-VEGF Antibody (ABIN115672)Product Details anti-VEGF Antibody Target Details VEGF Application Details Handling Images back to top
Kremer, Breier, Risau et al.: "Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system." in: Cancer research, Vol. 57, Issue 17, pp. 3852-9, 1997 (PubMed).
Fiebich, Jäger, Schöllmann et al.: "Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells." in: European journal of biochemistry / FEBS, Vol. 211, Issue 1-2, pp. 19-26, 1993 (PubMed).
Breier, Albrecht, Sterrer et al.: "Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation." in: Development (Cambridge, England), Vol. 114, Issue 2, pp. 521-32, 1992 (PubMed).